Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
Emerging computed tomography (CT) research suggests that marijuana smoking is associated with significantly elevated risks for centrilobular and paraseptal emphysema.
In a prospective multicenter study presented at the annual Radiological Society of North America (RSNA) conference in Chicago, researchers assessed and compared chest CT findings from cigarette smokers, regular marijuana smokers (four times a month and at least a two-year history of marijuana use), people who smoke marijuana and cigarettes, and non-smokers.
The researchers found that centrilobular emphysema, which involves damage to air sacs in the lungs, was 12 times more likely for people who smoke marijuana and cigarettes in comparison to non-smokers. People who only smoked marijuana had five- to seven-fold higher risks for paraseptal emphysema in contrast to non-smokers, according to the study authors.
“With our study, we show that there are physical effects of marijuana smoking on the lungs and that cigarette smoking and marijuana smoking may have a combined damaging effect on the lungs,” noted study co-author Jessie Kang, M.D., a cardiothoracic radiologist and assistant professor in the Department of Diagnostic Radiology at Dalhousie University in Halifax, Nova Scotia, Canada.
The study authors also found that bronchial wall thickening, which can lead to respiratory infection, scarring and further damage to airways, was four times more likely for people who smoked marijuana and cigarettes in comparison to non-smokers.
“The association between (marijuana) and smoking with bronchial wall thickening is significant, but interestingly, association with (marijuana) only and (cigarette) smoking only with bronchial wall thickening was not, suggesting that the combination of cigarette smoking and (marijuana) smoking may have a synergistic role on the lung/airways,” suggested Dr. Kang and her co-authors.
While there is a common perception that marijuana smoking is not as harmful as cigarette smoking, Dr. Kang said further research is essential to evaluate the long-term impact of marijuana smoking.
“More research needs to be done in this area, so the public can make an informed decision on their recreational usage of marijuana,” added Dr. Kang.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
